ETFs Are Net Sellers of Kenvue (KVUE) on Oct. 30
Are Wall Street Analysts Bullish on Kenvue Stock?
Kenvue (KVUE) Q3 Earnings Leave Margin Gains Under Legal Cloud
Kenvue (NYSE:KVUE) Posts Mixed Q3 2026 Results as Organic Growth and Kimberly-Clark Deal Offset EPS Miss
Kenvue (KVUE) Surpasses Q3 Earnings Estimates
Kenvue: Q3 Earnings Snapshot
Kenvue Reports Third Quarter 2026 Results
Kenvue's Q3 Earnings on the Horizon: Key Insights for Investors
Is Kenvue (KVUE) Below Fair Value After Its 40% Run?
What to Expect From Kenvue's Next Quarterly Earnings Report
Kimberly-Clark’s (KMB) Kenvue (KVUE) Deal Has Jim Cramer Looking Years Ahead
Kenvue (KVUE) Stock Still Appears 41% Undervalued On Cash Flow
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
Kenvue Inc's Dividend Analysis
Kimberly Clark (KMB) Lines Up Assets for $40 Billion Deal Review
Should Kenvue’s (KVUE) TYLENOL with Naproxen Launch and Dividend Plan Prompt Investor Reassessment?
Is Kenvue (KVUE) A Bargain Following Its TYLENOL With Naproxen Launch?
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand
Kenvue Declares Quarterly Cash Dividend
National Advertising Division Finds Hims & Hers Has Support for Combination Efficacy Message; Recommends Modification or Discontinuance of Other Claims
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.